Overall, impaired glucose control in PASC may develop either through low insulin secretion by the pancreas (T1DM progression) or impaired glucose metabolism and insulin resistance (T2DM progression) in major target tissues (adipose tissue, skeletal muscle, and liver) due to downregulation of insulin signaling pathways (178). This evidence concerns the gene INS and type 2 diabetes mellitus.